Tom Staab Insider Profile
11 Followers
Tom Staab, CFO at Tenax Therapeutics, holds 15.68K shares in Tenax Therapeutics (Ticker: TENX), holds 174.61K shares in LENSAR (Ticker: LNSR), holds 125.18K shares in BioCryst (Ticker: BCRX). Most recently, Tom Staab Bought ― shares of Tenax Therapeutics on Sep 15, 2026 for an estimated value of $10.95K.
Profitable Transactions
9 out of 11 Profitable Transactions
Average Return
+18.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Tom Staab holds in companies
Most Profitable Insider Trade
The most profitable trade made by Tom Staab
Tom Staab's Trading History
Tenax Therapeutics
Sep 15, 2026
CFO
Informative Buy
10.95K
$31.04K
BioCryst
May 20, 2019
SVP & CFO
Uninformative Sell
74.59K
$1.02M
LENSAR
May 08, 2026
CFO
Uninformative Sell
7.26K
$1.18M
List of latest transactions for each holding click on a transaction to see Tom Staab's performance on stock
You May Also Like
Tom Staab insider profile FAQ
What is the percentage of profitable transactions made by Tom Staab?
The percentage of profitable transactions made by Tom Staab is 82%.
What is the average return per transaction made by Tom Staab?
The average return per transaction made by Tom Staab is 18.30%.
What stocks does Tom Staab hold?
Tom Staab holds: TENX, BCRX, LNSR stocks.
What was Tom Staab’s latest transaction?
Tom Staab latest transaction was an Informative Buy of $10.95K.
What was Tom Staab's most profitable transaction?
Tom Staab’s most profitable transaction was an Informative Sell of BCRX stock on December 6, 2018. The return on the trade was 70.10%.
What is Tom Staab's role in Tenax Therapeutics?
Tom Staab's role in Tenax Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.